Key result
Visceral adiposity-driven hyperinsulinemia genetics linked to elevated MI risk selectively in males without diabetes.
Why the study?
Do specific clusters of fasting insulin-associated genetic variants differentially affect the risk of type 2 diabetes and cardiovascular disease?
Observational (n=1,100,000)
Do specific clusters of fasting insulin-associated genetic variants differentially affect the risk of type 2 diabetes and cardiovascular disease?
Answers are grounded in this paper and cite their sources.
Genetic variants associated with fasting insulin can be clustered into distinct mechanisms that decouple elevated fasting insulin levels from T2D and cardiovascular risk, highlighting process-specific pathways.
Elevated fasting insulin levels (FI), indicative of altered insulin secretion and sensitivity, may precede type 2 diabetes (T2D) and cardiovascular disease onset. In this study, we group FI-associated genetic variants based on their genetic and phenotypic similarities and identify seven clusters with distinct mechanisms contributing to elevated FI levels. Clusters fall into two types: “non-diabetogenic hyperinsulinemia,” where clusters are not associated with increased T2D risk, and “diabetogenic hyperinsulinemia,” where T2D associations are driven by body fat distribution, liver function, circulating lipids, or inflammation. In over 1.1 million multi-ancestry individuals, we demonstrated that diabetogenic hyperinsulinemia cluster-specific polygenic scores exhibit varying risks for cardiovascular conditions, including coronary artery disease, myocardial infarction (MI), and stroke. Notably, the visceral adiposity cluster shows sex-specific effects for MI risk in males without T2D. This study underscores processes that decouple elevated FI levels from T2D and cardiovascular risk, offering new avenues for investigating process-specific pathways of disease. Here, the authors implement a genetic approach grouping fasting insulin-associated genetic variants based on their genetic and phenotypic similarities and highlight specific processes that decouple increased fasting insulin levels from T2D and cardiovascular risk, offering potential avenues for investigating process-specific pathways of disease risk.
No takes yet. Share an insight, caveat, or question.
Sevilla-González et al. (2025) conducted an observational in Elevated fasting insulin levels (n=1,100,000). Fasting insulin-associated genetic variants (polygenic scores) was evaluated on Cardiovascular conditions, including coronary artery disease, myocardial infarction, and stroke. Diabetogenic hyperinsulinemia cluster-specific polygenic scores showed varying cardiovascular risks, with the visceral adiposity cluster showing sex-specific effects for MI in males without T2D.
Synapse has enriched 10 related papers. Consider them for comparative context: